[Drug-induced abnormal glucose tolerance].
Ogawa
Yoshiji
Y
Third Department of Internal Medicine, Hirosaki University School of Medicine.
Nakamura
Teruo
T
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001581:Benzothiadiazines; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004232:Diuretics; D005765:Gastrointestinal Agents / Q000009:adverse effects; D005938:Glucocorticoids / Q000009:adverse effects; D018149:Glucose Intolerance / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D014150:Antipsychotic Agents; D001581:Benzothiadiazines; D003278:Contraceptives, Oral, Hormonal; D004232:Diuretics; D005765:Gastrointestinal Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D049993:Sodium Chloride Symporter Inhibitors